The Clinical Presentation of Subclinical Hypothyroidism in Patients With Type 2 Diabetes Mellitus Associated With Obesity, Its Impact on Cardiovascular Risk, and Ways of Its Correction

Abstract

The aim: Calculate CVR in patients with T2DM, obesity and SH and analyze it. Materials and methods: The selection of patients was carried out based on the Uzhhorod District Clinical Hospital, in the period from November 2016 to July 2021. All examined patients were divided into 3 groups: 1 (n=108) with T2DM and concomitant obesity and SH, 2 (n=91) with T2DM and SH, 3 (n=46) with obesity and SH. The observation and treatment period lasted 1 year. Using American College of Cardiology (ACC) / American Heart Association Guideline on the Assessment of Cardiovascular Risk (AHAGACR) (2013) (ASCVD Risk) and Framingham Risk Score (FRS), CVR was determined in all patients before and at the end of the study. Results: According to the data obtained, patients in each group had a 10-year risk of CVE, however, worse CVR was observed in patients in group 1. In a more detailed analysis and comparison of the obtained data of patients with 10-year risk of CVE, worse CVR values were observed in patients with concomitant SH than without it (p<0.05). Conclusions: The presence of SH in consumers may be an additional risk factor for unwanted CVE over a 10-year period.